ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
M

A Genome-scale CRISPR Knock-out Screen in Chronic Myeloid Leukemia Identifies Common Drug Resistance Mechanisms Implicating Apoptotic and Transcriptional Machineries

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Matthieu Lewis
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Matthieu Lewis
19 views
January 2, 2019
Comments 0
Login to view comments. Click here to Login
Scientific Session 5: Mechanisms of Resistance and New Targets
15:26

A Genome-scale CRISPR Knock-out Screen in Chronic Myeloid Leukemia I…

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

M. Lewis

19 views
13:48

Single-molecule Sequencing Reveals Patterns of Pre-existing Drug Res…

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

J. Pritchard

15 views
12:49

Modulation of p53 with the MDM2 Antagonist Idasanutlin, in Combinati…

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

D. Vetrie

19 views